(RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):
-Earnings: -$17.58 million in Q2 vs. -$20.61 million in the same period last year. -EPS: -$0.10 in Q2 vs. -$0.12 in the same period last year. -Analysts projected -$0.13 per share -Revenue: $16.02 million in Q2 vs. $10.41 million in the same period last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.